Patents Examined by Satyendra Singh
-
Patent number: 8753689Abstract: Demineralized bone particles are obtained by demineralizing whole bone and thereafter subdividing the demineralized bone to provide the demineralized bone particles.Type: GrantFiled: September 9, 2013Date of Patent: June 17, 2014Assignee: Warsaw Orthopedic, Inc.Inventors: John W. Morris, Lawrence A. Shimp, Kenneth C. Petersen, Albert Manrique, David Kaes, Nelson Scarborough, Michael Dowd
-
Patent number: 8753806Abstract: An organ protectant solution which is intravenously administerable includes a high concentration of cell impermeant molecules which have a charge and/or molecular weight which permit passage across a capillary endothelium and into an interstitial space in said subject but which are too large and/or charged to cross a cell plasma membrane such that said one or more cell impermeant molecules preferentially load into an extracellular fluid compartment can be used to to allow for improved organ harvesting from DCD and brain death donors for transplantation purposes and also can be used extend the “Golden Hour” for traumatic and hemorrhagic shock patients thereby allowing more time for those patients to reach a point of care facility to receive medical treatment.Type: GrantFiled: August 20, 2012Date of Patent: June 17, 2014Assignee: Virginia Commonwealth UniversityInventor: Martin Mangino
-
Patent number: 8658391Abstract: The present invention provides methods for assessing the activity of topically administered chemodenervating agents. In some embodiments, methods for assessing the activity of topically administered chemodenervating agents involve determining the extent of inhibition of acetylcholine release near the site of administration. In some embodiments, methods for assessing activity of topically administered chemodenervating agents involve observing a reflex motion of a limb of a subject.Type: GrantFiled: April 27, 2007Date of Patent: February 25, 2014Assignee: Anterios, Inc.Inventor: Jonathan Edelson
-
Patent number: 8642285Abstract: A method for monitoring consumption or release of a gaseous analyte such as oxygen by a liquid sample under investigation includes providing a cuvette (1) having an elongate narrow tube (12) of a material which is substantially gas impermeable and which is at least partly transparent to measurement excitation radiation and emission radiation along some of the length of the tube. The tube (12) has a cross-sectional area of under 1 mm2. The sample (15) is loaded into the cuvette (1), the sample being in contact with a probe in the tube (12), the probe being sensitive to the gaseous analyte, and the liquid having at least one surface and an associated headspace (16). The cuvette, the sample, and the probe are equilibrated at a target measurement temperature. Excitation radiation is directed at a sampling zone of the tube (12) and which is distal from the headspace (16), while maintaining the cuvette at the measurement temperature.Type: GrantFiled: April 10, 2006Date of Patent: February 4, 2014Assignee: Luxcel Biosciences LimitedInventor: Dmitri Boris Papkovsky
-
Patent number: 8642288Abstract: Provided is a method of focusing particles. The method includes: providing a suspension of the particles in a suspending medium; and flowing the suspension along a channel, such that the flowing suspension occupies a certain volume that has at least one cross-sectional dimension smaller than 100 ?m. The suspending medium has such viscoelastic properties, that flowing the suspension in the channel directs at least some of the particles towards a focus region, enclosed in said certain volume.Type: GrantFiled: June 5, 2008Date of Patent: February 4, 2014Assignee: Technion Research & Development Foundation Ltd.Inventors: Alexander Leshansky, Avishay Bransky, Korin Natanel
-
Patent number: 8637066Abstract: A biocompatible ligament repair implant or scaffold device is provided for use in repairing a variety of ligament tissue injuries. The repair procedures may be conducted with ligament repair implants that contain a biological component that assists in healing or tissue repair. The biocompatible ligament repair implants include a biocompatible scaffold and particles of viable tissue derived from ligament tissue or tendon tissue, such that the tissue and the scaffold become associated. The particles of living tissue contain one or more viable cells that can migrate from the tissue and populate the scaffold.Type: GrantFiled: September 21, 2010Date of Patent: January 28, 2014Assignee: DePuy Mitek, LLCInventors: Francois Binnette, Julia Hwang, Mark Zimmerman, Mora Carolynne Melican
-
Patent number: 8603464Abstract: The present invention provides methods for using human placental alkaline phosphatase or an active derivative to reduce blood glucose level in a mammal. Treatment regimens provided by the invention may be used to control Type 1 and Type 2 forms of diabetes in humans. The methods and treatment regimens may be effective to maintain the human's blood glucose level below about 10 mM, and preferably within the normal range of 4 mM to 7 mM. The methods and treatment regimens may be used in combination with administration of known anti-diabetic medicaments. Also provided by the invention is a method for inducing weight loss or reducing an expected weight gain caused by or associated with obesity or Type 2 diabetes. The invention further provides a preparation for administration to a human, the preparation comprising homogeneous purified human placental alkaline phosphatase in a physiologically acceptable carrier.Type: GrantFiled: November 17, 2010Date of Patent: December 10, 2013Assignee: Zoltan Laboratories LLCInventor: Zoltan Kiss
-
Patent number: 8592198Abstract: The invention relates to a microorganism growth substrate which comprises a sterile nutrient composition derived from the biomass of a culture of bacteria including methanotrophic bacteria and further containing at least one sterile nutrient. A preferred biomass material is that derived from a microbial culture comprising Methylococcus capsulates (Bath) (strain NCIMB 41526), Ralstonia sp. DB3 (strain NCIMB 41527) and Brevibacillus agri DB5 (strain NCIMB 41525), optionally in combination with Aneurinibacillus sp. DB4 (strain NCIMB 41528).Type: GrantFiled: January 21, 2009Date of Patent: November 26, 2013Assignee: Statoil ASAInventors: Einar Moen, Jeanette Moller Jorgensen, Karen Moller Jensen, Arild Johannessen
-
Patent number: 8580558Abstract: This invention provides methods of isolating ferritin from plant and animal material. The isolated ferritin can be administered to humans or animals in need of iron, and can be used to treat or supplement iron deficiency. The isolated ferritin can be used in industrial applications, such as increasing the iron content in heat-processed food or beverages. The methods of the invention also include quantitation of iron derived from plant or animal ferritin.Type: GrantFiled: June 3, 2013Date of Patent: November 12, 2013Assignee: Slo-Iron, LLCInventor: Elizabeth C. Theil
-
Patent number: 8563251Abstract: The invention provides compositions (e.g., kits) and methods for determine the number of bacteria and other microbes in samples having low concentrations of microbes, for use, e.g., in biological warfare defense, microbe detection and agricultural and environmental sciences.Type: GrantFiled: May 11, 2007Date of Patent: October 22, 2013Assignee: San Diego State University (SDSU) FoundationInventors: Forest Rohwer, Linda Wegley
-
Patent number: 8562975Abstract: The present invention relates to a method for stabilizing reduced coenzyme Q10, which is useful as an ingredient in good foods, functional nutritive foods, specific health foods, nutritional supplements, nutrients, animal drugs, drinks, feeds, cosmetics, medicines, remedies, preventive drugs, etc., and to a composition therefor. The composition comprises reduced coenzyme Q10, a fat and oil (excluding olive oil) and/or a polyol, and doesn't substantially inhibit the stabilization of reduced coenzyme Q10. Additionally, the composition is a reduced coenzyme Q10-containing composition which comprises reduced coenzyme Q10, a polyglycerol fatty acid ester, and a fat and oil and/or a polyol.Type: GrantFiled: January 20, 2003Date of Patent: October 22, 2013Assignee: Kaneka CorporationInventors: Yasuyoshi Ueda, Takahiro Ueda, Tadao Ono, Shiro Kitamura, Kenji Fujii, Kazunori Hosoe
-
Patent number: 8545836Abstract: The present invention comprises methods and compositions for the reduction of oxalate in humans, animals and plants. For example, the invention provides methods and compositions for the delivery of one or more oxalate-reducing pharmaceutical compositions to the intestinal tracts of persons and animals. The methods and compositions can be used in treating and preventing oxalate-related conditions. A composition of the invention comprises an oral delivery vehicle comprising an oxalate degrading bacteria, one or more cryopreserving agents and one or more excipients. A composition of the invention is enteric coated and has a suitable shelf-life and acceptable properties to avoid negative impact from gastric fluid when it is orally administered.Type: GrantFiled: December 14, 2006Date of Patent: October 1, 2013Assignee: Oxthera, Inc.Inventors: Poonam Kaul, Harmeet Sidhu
-
Patent number: 8541182Abstract: Inflammatory state in a subject is assayed by determining the level of expression of A3 adenosine receptor (A3AR) in white blood cells (WBC), e.g. circulating WBCs, from the subject. A high level of expression of A3AR is indicative of an inflammatory state in the subject. This assay can be used for determining the severity of inflammation in a subject and monitoring the efficacy of anti-inflammatory treatment. Also, the level of expression may be used for selecting patients to receive an anti-inflammatory treatment that comprises an A3AR agonist.Type: GrantFiled: June 21, 2010Date of Patent: September 24, 2013Assignee: Can-Fite Biopharma Ltd.Inventors: Pnina Fishman, Sara Bar-Yehuda, Lea Madi
-
Patent number: 8535662Abstract: This invention provides new methods of treating subjects experiencing or at risk of bleeding due to vascular injury, especially to the microvasculature and/or platelet desensitization. Examples of injury usefully treated by apyrase agents are pathophysiological conditions, ischemia reperfusion injury, injury from pharmacologic agents such as anticoagulants, antiplatelet agents, antithrombotics, thrombolytics, and/or immunosuppressants, and injury resulting from transplantation. Apyrase agents are also useful to maintain organ function when said organs are transplanted into an allogeneic recipient.Type: GrantFiled: January 13, 2011Date of Patent: September 17, 2013Assignee: Apt Therapeutics, Inc.Inventors: Ridong Chen, Soon Seog Jeong
-
Patent number: 8529962Abstract: Demineralized bone particles are obtained by demineralizing whole bone and thereafter subdividing the demineralized bone to provide the demineralized bone particles.Type: GrantFiled: January 20, 2011Date of Patent: September 10, 2013Assignee: Warsaw Orthopedic, Inc.Inventors: John W. Morris, Lawrence A. Shimp, Kenneth C. Petersen, Albert Manrique, David Kaes, Nelson Scarborough, Michael Dowd
-
Patent number: 8524225Abstract: The present invention relates to a process for the proteolytic hydrolysis of a peptide or a polypeptide, said peptide or polypeptide comprising 4 to 40, preferably 5 to 35, amino acid residues and said peptide or polypeptide is not hydrolysable by subtilisin whereby said peptide or polypeptide is hydrolysed by a proline specific endo protease at a pH of 6.5 or lower, preferably 5.5 or lower and more preferably 5.0 or lower to hydrolyse said peptide or polypeptide.Type: GrantFiled: September 23, 2004Date of Patent: September 3, 2013Assignee: DSM IP Assets B.V.Inventors: Luppo Edens, Melissa Harvey, Robertus Antonius Mijndert Van Der Hoeven, Andre Leonardus De Roos
-
Patent number: 8506956Abstract: The present invention has its object to provide a method for stabilizing reduced coenzyme Q10, which is usable as foods, functional nutritive foods, specific health foods, nutritional supplements, nutrients, animal drugs, drinks, feeds, cosmetics, medicines, remedies, preventive drugs and the like. Reduced coenzyme Q10, which is readily oxidized in the air, is stabilized by causing ascorbic acid or a related compound thereof to coexist with a polyglycerol fatty acid ester with a polymerization degree of glycerol being not lower than 3 and/or a condensed ricinoleic acid polyglyceride in a mixture of the reduced coenzyme Q10 and an oil and fat.Type: GrantFiled: October 26, 2006Date of Patent: August 13, 2013Assignee: Kaneka CorporationInventors: Takahiro Ueda, Shiro Kitamura, Yasuyoshi Ueda
-
Patent number: 8501476Abstract: Provided are assays and methods for creating proto-tissues from aggregates of cells. The invention concerns assays and methods useful in tissue engineering and reconstruction techniques, specifically in the formation of macrotissues from microtissues using microtissue pre-culture time as a controlling parameter.Type: GrantFiled: October 1, 2010Date of Patent: August 6, 2013Assignee: Brown UniversityInventors: Jeffrey R. Morgan, Dylan Dean, Adam Rago
-
Patent number: 8496970Abstract: A conformable tissue implant is provided for use in repairing or augmenting a tissue defect or injury site. The tissue implant contains a tissue carrier matrix comprising a plurality of biocompatible, bioresorbable granules and at least one tissue fragment in association with the granules. The tissue fragment contains one or more viable cells that can migrate from the tissue and populate the tissue carrier matrix. Also provided is a method for injectably delivering the tissue implant.Type: GrantFiled: February 27, 2012Date of Patent: July 30, 2013Assignee: DePuy Mitek, LLCInventors: Francois Binette, Joseph J. Hammer, Krish Mukhopadhyay, Joel Rosenblatt
-
Patent number: 8481028Abstract: The invention relates to compositions for preparing a beverage, the compositions comprise a microorganism and/or an enzyme capable of hydrolysing chlorogenic acids of a coffee extract to phenolic acids. When a beverage prepared with the compositions of the invention is consumed chlorogenic acids present in coffee extract is hydrolysed to improve antioxidant and/or anti-inflammatory properties compared to a similar conventional beverage.Type: GrantFiled: March 12, 2009Date of Patent: July 9, 2013Assignee: Nestec S.A.Inventors: Rachid Bel-Rhlid, Karin Kraehenbuehl, Christophe Cavin, Thomas Wolfgang Raab, Nicolas Page